Modulating autoimmune responses to GAD inhibits disease progression and prolongs islet graft survival in diabetes–prone mice
Jide Tian(Beijing Normal University), Daniel L. Kaufman(University of California, Los Angeles), Yoko Mullen(City of Hope), Regula Mueller(Scripps Research Institute), Mark A. Atkinson(University of Florida), Seiji Arita(University of California, Los Angeles), Nora Sarvetnick(University of Nebraska Medical Center), Christopher J. Evans(University of Southern California), Michael Clere-Salzler(University of Florida), Paul Lehmann(University of California, Los Angeles), Douglas Newman(University of California, Los Angeles), Alan Herschenfeld(University of California, Los Angeles), Allan J. Tobin(Allen Institute for Brain Science), Blake Middleton(University of California, Los Angeles)
Cited by 259
Related Papers
Type 1 diabetes
|The Lancet|2013|2.7k
Type 1 diabetes: new perspectives on disease pathogenesis and treatment
|The Lancet|2001|1.5k
Staging Presymptomatic Type 1 Diabetes: A Scientific Statement of JDRF, the Endocrine Society, and the American Diabetes Association
|Diabetes Care|2015|1.2k
The Pathogenesis of Insulin-Dependent Diabetes Mellitus
|New England Journal of Medicine|1994|1.1k